000 01658 a2200445 4500
005 20250516184913.0
264 0 _c20150413
008 201504s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.2013.093690
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Loenen, Marleen M
245 0 0 _aA Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells.
_h[electronic resource]
260 _bHaematologica
_cApr 2014
300 _a759-68 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdoptive Transfer
650 0 4 _aBatch Cell Culture Techniques
_xmethods
650 0 4 _aHistocompatibility Antigens Class I
_xchemistry
650 0 4 _aHumans
650 0 4 _aImmunomagnetic Separation
650 0 4 _aLeukemia
_ximmunology
650 0 4 _aLymphocyte Activation
650 0 4 _aMinor Histocompatibility Antigens
_ximmunology
650 0 4 _aOligopeptides
_ximmunology
650 0 4 _aPeptides
_xchemistry
650 0 4 _aReceptors, Antigen, T-Cell
_ximmunology
650 0 4 _aT-Cell Antigen Receptor Specificity
_ximmunology
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTransduction, Genetic
650 0 4 _aViruses
_ximmunology
700 1 _ade Boer, Renate
700 1 _avan Liempt, Ellis
700 1 _aMeij, Pauline
700 1 _aJedema, Inge
700 1 _aFalkenburg, J H Frederik
700 1 _aHeemskerk, Mirjam H M
773 0 _tHaematologica
_gvol. 99
_gno. 4
_gp. 759-68
856 4 0 _uhttps://doi.org/10.3324/haematol.2013.093690
_zAvailable from publisher's website
999 _c23363544
_d23363544